Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
letter
. 1989 May;59(5):834. doi: 10.1038/bjc.1989.173

Breast cancer and the pill.

H Olsson, J Ranstam
PMCID: PMC2247240  PMID: 2736219

Full text

PDF

Page 834

834

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Kay C. R., Hannaford P. C. Breast cancer and the pill--a further report from the Royal College of General Practitioners' oral contraception study. Br J Cancer. 1988 Nov;58(5):675–680. doi: 10.1038/bjc.1988.285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Matthews P. N., Millis R. R., Hayward J. L. Breast cancer in women who have taken contraceptive steroids. Br Med J (Clin Res Ed) 1981 Mar 7;282(6266):774–776. doi: 10.1136/bmj.282.6266.774. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Millard F. C., Bliss J. M., Chilvers C. E., Gazet J. C. Oral contraceptives and survival in breast cancer. Br J Cancer. 1987 Sep;56(3):377–378. doi: 10.1038/bjc.1987.206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Olsson H., Borg A., Ewers S. B., Fernö M., Möller T., Ranstam J. A biological marker, strongly associated with early oral contraceptive use, for the selection of a high risk group for premenopausal breast cancer. Med Oncol Tumor Pharmacother. 1986;3(2):77–81. doi: 10.1007/BF02934557. [DOI] [PubMed] [Google Scholar]
  5. Olsson H., Lindahl B., Ranstam J., Borg A., Fernö M., Norgren A. Permanent alterations induced in plasma prolactin and estrogen receptor concentration in benign and malignant tissue of women who started oral contraceptive use at an early age. Anticancer Res. 1987 Jul-Aug;7(4B):853–856. [PubMed] [Google Scholar]
  6. Olsson H., Möller T. R., Ranstam J., Borg A., Fernö M. Early oral contraceptive use as a prognostic factor in breast cancer. Anticancer Res. 1988 Jan-Feb;8(1):29–32. [PubMed] [Google Scholar]
  7. Olsson H., Olsson M. L., Möller T. R., Ranstam J., Holm P. Oral contraceptive use and breast cancer in young women in Sweden. Lancet. 1985 Mar 30;1(8431):748–749. doi: 10.1016/s0140-6736(85)91280-2. [DOI] [PubMed] [Google Scholar]
  8. Rosner D. H., Joy J. V., Lane W. W. Oral contraceptives and prognosis of breast cancer in women aged 35 to 50. J Surg Oncol. 1985 Sep;30(1):52–59. doi: 10.1002/jso.2930300114. [DOI] [PubMed] [Google Scholar]
  9. Rosner D., Lane W. W., Perez Brett R. Influence of oral contraceptives on the prognosis of breast cancer in young women. Cancer. 1985 Apr 1;55(7):1556–1562. doi: 10.1002/1097-0142(19850401)55:7<1556::aid-cncr2820550724>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  10. Spencer J. D., Millis R. R., Hayward J. L. Contraceptive steroids and breast cancer. Br Med J. 1978 Apr 22;1(6119):1024–1026. doi: 10.1136/bmj.1.6119.1024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Vessey M., Baron J., Doll R., McPherson K., Yeates D. Oral contraceptives and breast cancer: final report of an epidemiological study. Br J Cancer. 1983 Apr;47(4):455–462. doi: 10.1038/bjc.1983.74. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES